PH22293A - Thienopyridone compounds and compositions with therapeutic activity - Google Patents

Thienopyridone compounds and compositions with therapeutic activity

Info

Publication number
PH22293A
PH22293A PH33869A PH33869A PH22293A PH 22293 A PH22293 A PH 22293A PH 33869 A PH33869 A PH 33869A PH 33869 A PH33869 A PH 33869A PH 22293 A PH22293 A PH 22293A
Authority
PH
Philippines
Prior art keywords
compositions
therapeutic activity
thienopyridone
compounds
thienopyridone compounds
Prior art date
Application number
PH33869A
Other languages
English (en)
Inventor
Davies Roy Victor
Fraser James
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of PH22293A publication Critical patent/PH22293A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH33869A 1985-06-15 1986-06-09 Thienopyridone compounds and compositions with therapeutic activity PH22293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858515207A GB8515207D0 (en) 1985-06-15 1985-06-15 Therapeutic agents

Publications (1)

Publication Number Publication Date
PH22293A true PH22293A (en) 1988-07-22

Family

ID=10580803

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33869A PH22293A (en) 1985-06-15 1986-06-09 Thienopyridone compounds and compositions with therapeutic activity

Country Status (20)

Country Link
US (1) US4710506A (da)
EP (1) EP0209977A3 (da)
JP (1) JPS6236382A (da)
KR (1) KR870000339A (da)
AU (1) AU581595B2 (da)
CS (1) CS258483B2 (da)
DD (1) DD253823A5 (da)
DK (1) DK272486A (da)
ES (1) ES8707243A1 (da)
FI (1) FI862520A (da)
GB (1) GB8515207D0 (da)
GR (1) GR861527B (da)
HU (1) HU195661B (da)
JO (1) JO1482B1 (da)
NO (1) NO862373L (da)
PH (1) PH22293A (da)
PL (1) PL266392A1 (da)
PT (1) PT82759B (da)
YU (2) YU99386A (da)
ZA (1) ZA864396B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
US4767766A (en) * 1987-01-30 1988-08-30 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors
US4904672A (en) * 1987-01-30 1990-02-27 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
AU5509099A (en) * 1998-08-03 2000-02-28 Basf Corporation Pyridinones for the treatment of sexual dysfunction
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
CN101624391A (zh) * 2001-06-11 2010-01-13 病毒化学医药公司 用作黄病毒感染抗病毒剂的噻吩衍生物
US6995171B2 (en) * 2001-06-21 2006-02-07 Agouron Pharmaceuticals, Inc. Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents
CN100413861C (zh) * 2002-12-10 2008-08-27 维勒凯姆制药股份有限公司 用于治疗或预防黄病毒感染的化合物
US7994192B2 (en) * 2006-09-26 2011-08-09 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
US8697720B2 (en) 2006-09-26 2014-04-15 Crestone, Inc. Substituted phenylether-thienopyridone compounds with antibacterial activity
US7973050B2 (en) * 2006-09-26 2011-07-05 Crestone, Inc. Enantiomeric compounds with antibacterial activity
US8658670B2 (en) * 2006-09-26 2014-02-25 Crestone, Inc. Methods and compounds for treatment of clostridium based infection
ES2392897T3 (es) * 2006-09-26 2012-12-14 Crestone, Inc. Compuestos tienopiridona sustituidos con actividad antibacteriana
EP2559692A1 (en) 2006-11-15 2013-02-20 Virochem Pharma Inc. Thiophene analogues for the treatment or prevention of Flavivirus infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997545A (en) * 1973-07-23 1976-12-14 Takeda Chemical Industries, Ltd. Thienopyridine-carboxylic acid derivatives
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
JPS5742690A (en) * 1980-08-28 1982-03-10 Kanebo Ltd Thieno 3,2-b pyridinecarboxylic acid derivative
GB2085441B (en) * 1980-09-26 1984-10-17 Boots The Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
DE3412947A1 (de) * 1984-04-06 1985-10-17 Bayer Ag, 5090 Leverkusen Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
CS436286A2 (en) 1987-12-17
DK272486D0 (da) 1986-06-10
JPS6236382A (ja) 1987-02-17
EP0209977A2 (en) 1987-01-28
HUT42775A (en) 1987-08-28
ES8707243A1 (es) 1987-07-16
GB8515207D0 (en) 1985-07-17
CS258483B2 (en) 1988-08-16
ZA864396B (en) 1987-08-26
NO862373L (no) 1986-12-16
FI862520A0 (fi) 1986-06-12
NO862373D0 (no) 1986-06-13
EP0209977A3 (en) 1988-06-08
HU195661B (en) 1988-06-28
AU581595B2 (en) 1989-02-23
DD253823A5 (de) 1988-02-03
FI862520A (fi) 1986-12-16
US4710506A (en) 1987-12-01
PL266392A1 (en) 1988-02-18
GR861527B (en) 1986-10-14
KR870000339A (ko) 1987-02-17
YU99386A (en) 1988-04-30
AU5838386A (en) 1986-12-18
JO1482B1 (en) 1988-03-10
YU121187A (en) 1988-04-30
PT82759A (en) 1986-07-01
DK272486A (da) 1986-12-16
ES556026A0 (es) 1987-07-16
PT82759B (en) 1988-05-12

Similar Documents

Publication Publication Date Title
ZA868529B (en) Effervescent composition with analgesic activity
DE3666855D1 (en) Alcalisilicate compositions and their use
IL78934A0 (en) Alfuzosine compositions and use
GR871197B (en) Pharmaceutical composition with analgesic activity
PH22293A (en) Thienopyridone compounds and compositions with therapeutic activity
GB2181349B (en) Skin care composition
GB2184653B (en) Dementia-improving and therapeutic agents
GB8521275D0 (en) Therapeutic composition
PT82760A (en) Therapeutic agents
GR861712B (en) Medicaments and their use
GB8630251D0 (en) Therapeutic composition
GB8629568D0 (en) Therapeutic agent
GB2183235B (en) Substituted benzylhydroxylamines and their use as stabilizers
GB8508404D0 (en) Therapeutic compositions
ZA859770B (en) Synergistic combination of flupirtin and 4-acetamido-phenol
GB2171013B (en) Skin care composition
IL80430A0 (en) Pyridinylurea compounds and agricultural uses
GR860180B (en) Compositions and their use
GB8529885D0 (en) Therapeutic agent
GB2188046B (en) Hydroxymethylcephem compounds and their preparation
GB8521342D0 (en) Medicament
GB8504189D0 (en) Therapeutic agent
GB8502604D0 (en) Therapeutic agent
GB8514634D0 (en) Therapeutic agents
GB8503626D0 (en) Therapeutic agents